Cargando…
Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström Macroglobulinemia
Waldenström Macroglobulinemia (WM) is a proliferative disorder of IgM secreting, lymphoplasmacytoid cells that inhabit the lymph nodes and bone marrow. The disease carries a high prevalence of activating mutations in MyD88 (91%) and CXCR4 (28%). Because signaling through these pathways leads to Bcl-...
Autores principales: | Gaudette, Brian T., Dwivedi, Bhakti, Chitta, Kasyapa S., Poulain, Stéphanie, Powell, Doris, Vertino, Paula, Leleu, Xavier, Lonial, Sagar, Chanan-Khan, Asher A., Kowalski, Jeanne, Boise, Lawrence H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874246/ https://www.ncbi.nlm.nih.gov/pubmed/25893290 http://dx.doi.org/10.1038/onc.2015.103 |
Ejemplares similares
-
Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications
por: Paulus, Aneel, et al.
Publicado: (2015) -
Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia
por: Chitta, K, et al.
Publicado: (2014) -
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022) -
Role of IRF4 in resistance to immunomodulatory (IMid) compounds(®) in Waldenström’s macroglobulinemia
por: Bertrand, Elisabeth, et al.
Publicado: (2017) -
Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia
por: Amalnath, S. D., et al.
Publicado: (2013)